An Open Label Dose Escalation Study to Evaluate the Safety of Administration of Non-Viral SDF-1 Plasmid to Treat Symptomatic Ischemic Heart Failure
Presenter: 195098|Marc Penn
Up Next
Presenter: Elliot Smith
More slides +
Presenter: Etsuo Tsuchikane
Presenter: Georgios Sianos